Subject(s)
Science , United States Government Agencies , Inventions/economics , Inventions/legislation & jurisprudence , Science/economics , Science/legislation & jurisprudence , United States , United States Government Agencies/economics , United States Government Agencies/legislation & jurisprudenceSubject(s)
HIV Infections , United States Government Agencies , Humans , Africa/epidemiology , HIV Infections/drug therapy , HIV Infections/economics , HIV Infections/epidemiology , HIV Infections/prevention & control , United States , United States Government Agencies/economics , United States Government Agencies/organization & administration , International CooperationSubject(s)
Biomedical Research , Budgets , Risk-Taking , United States Government Agencies , United States , National Institutes of Health (U.S.)/organization & administration , National Institutes of Health (U.S.)/trends , Humans , United States Government Agencies/economics , United States Government Agencies/organization & administration , United States Government Agencies/trends , Biomedical Research/economics , Biomedical Research/organization & administration , Biomedical Research/trendsSubject(s)
Neoplasms , United States Government Agencies , Biomedical Research/economics , Biomedical Research/organization & administration , Health Equity , Humans , Neoplasms/diagnosis , Neoplasms/mortality , Neoplasms/prevention & control , Neoplasms/therapy , United States , United States Government Agencies/economics , United States Government Agencies/legislation & jurisprudence , United States Government Agencies/organization & administrationSubject(s)
Financing, Organized/legislation & jurisprudence , Internationality/legislation & jurisprudence , Research Personnel/ethics , Research Personnel/legislation & jurisprudence , Research Support as Topic/legislation & jurisprudence , United States Government Agencies/legislation & jurisprudence , China , Confidentiality/legislation & jurisprudence , Conflict of Interest/legislation & jurisprudence , Financing, Organized/organization & administration , Fraud/legislation & jurisprudence , National Institutes of Health (U.S.)/economics , National Institutes of Health (U.S.)/legislation & jurisprudence , Personnel Selection/ethics , Personnel Selection/legislation & jurisprudence , Research Support as Topic/ethics , United States , United States Government Agencies/economics , Universities/economics , Universities/legislation & jurisprudenceABSTRACT
Does president Trump's use of Twitter affect financial markets? The president frequently mentions companies in his tweets and, as such, tries to gain leverage over their behavior. We analyze the effect of president Trump's Twitter messages that specifically mention a company name on its stock market returns. We find that tweets from the president which reveal strong negative sentiment are followed by reduced market value of the company mentioned, whereas supportive tweets do not render a significant effect. Our methodology does not allow us to conclude about the exact mechanism behind these findings and can only be used to investigate short-term effects.
Subject(s)
Politics , Social Media/economics , United States Government Agencies/economics , Decision Making, Shared , Humans , United StatesSubject(s)
Budgets/legislation & jurisprudence , Science/economics , Science/legislation & jurisprudence , United States Government Agencies/economics , United States Government Agencies/legislation & jurisprudence , Biomedical Research/economics , Biomedical Research/legislation & jurisprudence , National Institutes of Health (U.S.)/economics , United States , United States Environmental Protection Agency/economics , United States Environmental Protection Agency/legislation & jurisprudence , United States National Aeronautics and Space Administration/economics , United States National Aeronautics and Space Administration/legislation & jurisprudenceSubject(s)
Budgets/legislation & jurisprudence , Cyclonic Storms/economics , Science/economics , United States Government Agencies/economics , United States Government Agencies/legislation & jurisprudence , Research Support as Topic/economics , Research Support as Topic/legislation & jurisprudence , Science/legislation & jurisprudence , Science/organization & administration , United States , United States National Aeronautics and Space Administration/economics , United States National Aeronautics and Space Administration/legislation & jurisprudenceSubject(s)
Budgets/legislation & jurisprudence , Research Support as Topic/economics , Research Support as Topic/legislation & jurisprudence , Science/economics , Science/legislation & jurisprudence , United States Government Agencies/economics , United States Government Agencies/legislation & jurisprudence , Centers for Disease Control and Prevention, U.S./economics , Humans , National Institutes of Health (U.S.)/economics , United States , United States Environmental Protection Agency/economics , United States Food and Drug Administration/economics , United States National Aeronautics and Space Administration/economicsSubject(s)
Public Policy/legislation & jurisprudence , Public Policy/trends , Science/legislation & jurisprudence , Science/organization & administration , United States Government Agencies/legislation & jurisprudence , United States Government Agencies/organization & administration , National Institute of Environmental Health Sciences (U.S.)/economics , National Institute of Environmental Health Sciences (U.S.)/organization & administration , Research/economics , Research/legislation & jurisprudence , Research/organization & administration , Research/trends , Science/economics , Science/trends , Time Factors , Uncertainty , United States , United States Government Agencies/economics , United States Government Agencies/trends , United States National Aeronautics and Space Administration/organization & administrationSubject(s)
Budgets/legislation & jurisprudence , Federal Government , Science/economics , Uncertainty , United States Government Agencies/economics , Humans , National Institutes of Health (U.S.)/economics , Science/legislation & jurisprudence , United States , United States Government Agencies/legislation & jurisprudence , United States National Aeronautics and Space Administration/economics , Zika Virus Infection/economics , Zika Virus Infection/prevention & controlABSTRACT
This latest article in the Federal Funding for Health Security series assesses FY2017 US government funding in 5 domains critical to strengthening health security: biosecurity, radiological and nuclear security, chemical security, pandemic influenza and emerging infectious disease, and multiple-hazard and general preparedness.